Fingerprint Development and Analysis investigations FDAi
Validation Who it's for Register interest
In validation — not yet released

Fingerprint Development and Analysis in investigations.

Get the optimal sequence, with minimal disruption of evidence.

Fingerprint Development Analysis investigation (FDAi) is a subscription knowledge base for forensic evidence processing. Describe an exhibit and its case context; receive a cited cross-discipline processing sequence with fingerprint development placed correctly — together with an account of what would compromise the evidence that comes after it.
That didn't go through. Please write directly to marcel@marceldepuit.com.
Noted. We'll write to {{ email }} when FingerprintAI opens to practitioners. No other correspondence.
Launch notification only. Institutional & validation enquiries →

Decision support and second opinion.
Your own validated SOP always governs.
Stay up to date with the latest scientific developments and possibilities.

01 — The problem

Order of treatment decides what survives.

Sequencing errors are irreversible

A technique applied out of order can consume, contaminate or obscure the material a later discipline needs. The loss is rarely visible at the bench and cannot be undone once the exhibit has been treated.

The reference is scattered

Guidance sits across manuals, review literature, source books and local protocols. Reconciling fingermark development with DNA, trace, documents and digital recovery is left to individual judgement under time pressure.

Cross-discipline experience is uneven

Few practitioners can hold the full multidisciplinary picture for every substrate and case type. Unusual exhibits are exactly where a considered second opinion is hardest to obtain quickly.

02 — What it does

Describe the exhibit. Read the sequence — and the warnings.

Substrate, condition, contaminants, what is being sought, what the case requires. The response places fingermark development correctly within the wider recovery order and cites the literature behind each step.

The negative guidance is the part practitioners ask for first: what not to do on this exhibit, and what it would cost downstream.

Illustrative output DECISION SUPPORT
Exhibit as described

Polyethylene carrier bag, recovered dry from an indoor scene. Fingermarks and DNA both sought. Handles handled by multiple persons; possible drug residue inside.

Proposed order of treatment
01
Visual examination and forensic light source
Non-destructive record of trace material before any contact treatment. Any patent marks or partials present are photographed at this stage.
Initial examination FVM 2nd ed. §3 ↗
02
Targeted DNA sampling of handle contact areas
Taken before chemical development, with sampling positions recorded against the mark search plan.
03
Cyanoacrylate fuming, then dye stain and fluorescence examination
Primary development route for non-porous polyethylene held dry; fluorescence examination before any further chemistry.
Fingermarks Interpol Review
04
Photography of developed marks, then a second DNA swab of the marks
Image every visualised or developed mark, including partials whose visibility has improved after fuming, before swabbing those marks for DNA.
Imaging DNA
05
Interior residue recovery, or VMD
Deferred until mark development, imaging and swabbing are complete and documented.
Chemistry Fingermarks
What not to do — and why
Do not powder before DNA sampling. Brush contact redistributes and dilutes contact traces on the handles, and the sampling record can no longer be tied cleanly to untouched areas.
Do not apply solvent-based chemistry ahead of fuming. On this substrate it risks removing the very residue the primary development route depends on.
Do not recover interior residue first. Handling for residue collection introduces fresh deposits and mechanical damage across the surfaces still to be searched for marks.
03 — How it works
1

Describe the exhibit and context

Substrate and condition, how it was recovered, what is being sought, and any constraints the case imposes. Plain language, as you would brief a colleague.

2

Receive a cited sequence

An ordered cross-discipline treatment plan with fingermark development placed correctly, each step referenced to the corpus, plus the contra-indications for that exhibit.

3

Apply under your own SOP

You remain the decision-maker. The output is a second opinion to weigh against your laboratory's validated procedures, accreditation scope and available capability.

04 — VALIDATION

The science is core.

Nothing is generated from open web material - FDAi is a closed book Ai knowledgebase, is assembled from peer reviewd forensic literature. Every step returned carries its citation so it can be verified at any stage.

PUBLISHED DEVELOPMENT SEQUENCE

The core of FDAi lies in peer-reviewed publications and leading manuals and textbooks; Fingermark Visualisation Manual, 2nd edition (2022) and the Fingermark Visualisation Source Book v3.0.

Cross-validation

Reviewed with leading scientists and specialists from forensic providers and universities. Ratification is ongoing; the product remains in validation and is not offered for casework use yet.

05 — Who it's for

Practitioners

Fingermark and evidence examiners who need guidance or a second opinion on an unfamiliar substrate or a competing-priorities exhibit, before the first treatment is applied.

Laboratories

Lab leads and quality managers using a common reference for triage discussions, training, and consistency of sequencing decisions across teams and shifts.

Institutions

Universities, professional bodies and national units contributing review, curriculum use, or validation studies as the corpus is extended across disciplines.

Waitlist

Get notified at launch

One message when FingerprintAI opens to practitioners, with the scope of the first release and the disciplines covered.
Registered as {{ email }}.
Institutional

Partner or validation enquiry

For laboratories, professional bodies and university departments interested in review, ratification, validation studies or pilot access. Please include your organisation and role.

Write to us